Welcome to the WCN 2021 Interactive Program

The congress will officially run on Central European Time (CET) - Rome Time 
To convert the congress times to your local time 
Click Here

    Please note that all sessions will run at their scheduled time and be followed by a LIVE Q&A/Discussion at the end

     The viewing of sessions, cannot be accessed from this conference calendar. All sessions are accessible via the Virtual Platform

Displaying One Session

Sponsored Symposium
Session Time
14:00 - 15:30
Room
Industry 1
Chair(s)
  • Massimo Filippi (Italy)
  • Carlo Pozzilli (Italy)
  • Antonio Uccelli (Italy)
Session Description
Eculizumab as a new therapeutic option in rare neurological diseases
This symposium aims to:
- Spread the knowledge of a pathophysiologic mechanism that not many clinicians know properly, but that is proven to be one of the trigger causes of NMOSD (Neuromyelitis Optica Spectrum Disorder) and gMG (generalized Myasthenia Gravis), two immune mediated rare neurological diseases.
- Present data for eculizumab on both diseases and highlight innovation in therapeutic environment thanks to the discussion with experts.
Sponsored Symposium

Eculizumab as a new therapeutic option in rare neurological diseases

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
14:00 - 14:00
Sponsored Symposium

Supported by Alexion

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
14:00 - 14:00
Sponsored Symposium

Welcome and introduction

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
14:00 - 14:05
Presenter
  • Antonio Uccelli (Italy)
  • Carlo Pozzilli (Italy)
Sponsored Symposium

Discover how the complement system plays a role in NMOSD and gMG

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
14:05 - 14:20
Presenter
  • Roberto Furlan (Italy)
Sponsored Symposium

Can we regain control of daily life activities for refractory gMG patients?

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
14:20 - 14:35
Presenter
  • Renato Mantegazza (Italy)
Sponsored Symposium

One relapse is one too many: can we prevent damage for relapsing NMOSD patients?

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
14:35 - 14:50
Presenter
  • Diego Centonze (Italy)
Sponsored Symposium

Q&A

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
14:50 - 15:00
Presenter
  • Roberto Furlan (Italy)
  • Renato Mantegazza (Italy)
  • Diego Centonze (Italy)
  • Amelia Evoli (Italy)
  • Maria Trojano (Italy)
  • Luca Pani (Italy)
Sponsored Symposium

Discussion with a board of specialists on the value of eculizumab being the first therapy approved in NMOSD and gMG

Session Type
Sponsored Symposium
Date
03.10.2021, Sunday
Session Time
14:00 - 15:30
Room
Industry 1
Lecture Time
15:00 - 15:30
Presenter
  • Amelia Evoli (Italy)
  • Maria Trojano (Italy)
  • Luca Pani (Italy)
  • Roberto Furlan (Italy)
  • Renato Mantegazza (Italy)
  • Diego Centonze (Italy)